Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - leflunomide 20mg - film coated tablet - 20 mg - active: leflunomide 20mg excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide yellow lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g);  ;   - powder for oral solution - 1.7 meq/g - active: calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g)     excipient: saccharin vanillin

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - metronidazole 500mg - suppository - 500 mg - active: metronidazole 500mg excipient: hard fat

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - fludarabine phosphate 10mg - film coated tablet - 10 mg - active: fludarabine phosphate 10mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - the treatment of b-cell chronic lympocytic leukaemia.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 100 iu/ml equivalent to 3.6378 mg/ml - solution for injection - 100 iu/ml - active: insulin glargine 100 iu/ml equivalent to 3.6378 mg/ml excipient: glycerol hydrochloric acid metacresol polysorbate 20 sodium hydroxide water for injection zinc chloride - lantus is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 3.6378 mg/ml (100 iu/ml) - solution for injection - 100 iu/ml - active: insulin glargine 3.6378 mg/ml (100 iu/ml) excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc chloride - lantus is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] - suspension for injection - 2.5 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] excipient: albumin neomycin sulfate water for injection - post exposure immunisation against rabies. pre-exposure immunisation in persons at special risk of contracting rabies.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.5mg;   - pessary - 0.5 mg - active: estriol 0.5mg   excipient: hard fat - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 2mg;   - tablet - 2 mg - active: estriol 2mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate potato starch povidone - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. climacteric complaints such as hot flushes and night sweating. a diagnostic aid in case of a doubtful atropic cervical smear. infertility due to cervical hostility.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.1%{relative};   - vaginal cream - 0.1 % - active: estriol 0.1%{relative}   excipient: cetyl alcohol chlorhexidine hydrochloride glycerol lactic acid octyldodecanol polysorbate 60 purified water sodium hydroxide sorbitan stearate spermaceti stearyl alcohol - atrophy of the lower urogenital tract related to oestrogen deficiency, notably: · for the treatment of vaginal complaints such as dyspareunia, dryness and itching. · for the prevention of recurrent infections of the vagina and lower urinary tract. · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and post-operative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.